Pharmacokinetic and pharmacodynamic properties of SOL1: a novel dual inhibitor of neutral endopeptidase and endothelin converting enzyme. [electronic resource]
Producer: 20130107Description: 587-92 p. digitalISSN:- 1879-0631
- Animals
- Aspartic Acid Endopeptidases -- antagonists & inhibitors
- Benzazepines -- administration & dosage
- Blood Pressure -- drug effects
- Desoxycorticosterone -- toxicity
- Disease Models, Animal
- Endothelin-Converting Enzymes
- Enzyme Inhibitors -- administration & dosage
- Half-Life
- Humans
- Hydrogen-Ion Concentration
- Hypertension -- drug therapy
- Inhibitory Concentration 50
- Male
- Metalloendopeptidases -- antagonists & inhibitors
- Mice
- Mice, Inbred C57BL
- Neprilysin -- antagonists & inhibitors
- Rats
- Rats, Sprague-Dawley
- Rats, Wistar
- Sodium Chloride, Dietary -- toxicity
- Tissue Distribution
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.